IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 401 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $1,024,000 | -0.1% | 17,084 | -0.2% | 0.01% | -14.3% |
Q3 2019 | $1,025,000 | -1.4% | 17,112 | +6.4% | 0.01% | -12.5% |
Q2 2019 | $1,040,000 | -19.6% | 16,084 | +1.0% | 0.01% | -20.0% |
Q1 2019 | $1,294,000 | +58.0% | 15,930 | +5.3% | 0.01% | +42.9% |
Q4 2018 | $819,000 | -10.7% | 15,133 | -14.8% | 0.01% | -12.5% |
Q3 2018 | $917,000 | +13.9% | 17,762 | -2.6% | 0.01% | 0.0% |
Q2 2018 | $805,000 | 0.0% | 18,240 | 0.0% | 0.01% | 0.0% |
Q1 2018 | $805,000 | -7.4% | 18,240 | +5.6% | 0.01% | 0.0% |
Q4 2017 | $869,000 | -1.5% | 17,267 | -0.7% | 0.01% | -20.0% |
Q3 2017 | $882,000 | -0.6% | 17,387 | -0.2% | 0.01% | 0.0% |
Q2 2017 | $887,000 | +29.7% | 17,418 | +2.3% | 0.01% | +11.1% |
Q1 2017 | $684,000 | -11.3% | 17,034 | +5.6% | 0.01% | -18.2% |
Q4 2016 | $771,000 | +6.9% | 16,127 | -18.0% | 0.01% | 0.0% |
Q3 2016 | $721,000 | +66.9% | 19,674 | +6.1% | 0.01% | +57.1% |
Q2 2016 | $432,000 | -15.0% | 18,540 | +47.8% | 0.01% | -22.2% |
Q1 2016 | $508,000 | -21.5% | 12,546 | +20.0% | 0.01% | -25.0% |
Q4 2015 | $647,000 | – | 10,455 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |